Section 431A.860 - [Operative until 1/1/2025] Duty of pharmacy to report to program; exceptions(1) Not later than 72 hours after dispensing a prescription drug that is subject to the prescription monitoring program established under ORS 431A.855, a pharmacy shall electronically report to the Oregon Health Authority: (a) For prescription drugs described in ORS 431A.855 (1)(a)(A) and other drugs identified by the authority by rule, the name, address, phone number, date of birth and sex of the patient for whom the prescription drug was prescribed;(b) The identity of the pharmacy that dispensed the prescription drug and the date on which the prescription drug was dispensed;(c) The identity of the practitioner who prescribed the prescription drug and the date on which the prescription drug was prescribed;(d) The national drug code number for the prescription drug;(e) The prescription number assigned to the prescription drug;(f) The quantity of the prescription drug dispensed;(g) The number of days for which the prescription drug was dispensed;(h) The number of refills of the prescription authorized by the practitioner and the number of the refill that the pharmacy dispensed; and(i) The diagnosis code used by the practitioner and the reason for the prescription.(2) Notwithstanding subsection (1) of this section, the authority may not:(a) Require the reporting of prescription drugs administered directly to a patient or dispensed pursuant to ORS 127.800 to 127.897; or(b) Collect or use Social Security numbers in the prescription monitoring program.(3) Upon receipt of the data reported pursuant to subsection (1) of this section, the authority shall record the data in the electronic system established under ORS 431A.855.(4)(a) The authority may, for good cause as determined by the authority, grant a pharmacy a waiver of the requirement that the information to be reported under subsection (1) of this section be submitted electronically. The waiver must state the format, method and frequency of the alternate nonelectronic submissions from the pharmacy and the duration of the waiver.(b) As used in this subsection, "good cause" includes financial hardship.(5) This section does not apply to pharmacies in institutions as defined in ORS 179.010.Amended by 2019 Ch. 470, § 6, eff. 9/29/2019.Amended by 2017 Ch. 683, § 13, eff. 10/6/2017, op. 1/1/2018.This section is set out more than once due to postponed, multiple, or conflicting amendments.